000 01397 a2200433 4500
005 20250516002626.0
264 0 _c20110331
008 201103s 0 0 eng d
022 _a1421-9867
024 7 _a10.1159/000315898
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHorjus, C S
245 0 0 _aMicroalbuminuria is not a valuable marker for relapse in Crohn's disease.
_h[electronic resource]
260 _bDigestion
_c2011
300 _a41-5 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAlbuminuria
_xetiology
650 0 4 _aAnti-Inflammatory Agents
_xadministration & dosage
650 0 4 _aBiomarkers
_xurine
650 0 4 _aBudesonide
_xadministration & dosage
650 0 4 _aCrohn Disease
_xdiagnosis
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLogistic Models
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPredictive Value of Tests
650 0 4 _aProportional Hazards Models
650 0 4 _aProspective Studies
650 0 4 _aRecurrence
650 0 4 _aYoung Adult
700 1 _avan Oijen, M G H
700 1 _aDavids, A H
700 1 _aNaber, A H J
700 1 _ade Jong, D J
773 0 _tDigestion
_gvol. 83
_gno. 1-2
_gp. 41-5
856 4 0 _uhttps://doi.org/10.1159/000315898
_zAvailable from publisher's website
999 _c20178048
_d20178048